CD14 and neoplasm: However, analysis of all three immune markers simultaneously revealed that both intraepithelial CD3+ T cells and the intraepithelial CD14+rest− monocytes were the only independent prognostic markers, irrespective of tumor stage and molecular subtype (Table 1).